nach oben

Erschienen in:

10.11.2016 | Original articles

Association between microRNA polymorphisms and coronary heart disease

A meta-analysis

verfasst von: X. Xie, MD, X. Shi, MD, X. Xun, BS, L. Rao, MD, PhD

Erschienen in: Herz | Ausgabe 6/2017

Einloggen, um Zugang zu erhalten

Abstract

The association between microRNA polymorphisms (miR polymorphisms) and coronary heart disease (CHD) risk has been studied intensively, but the results have been conflicting. Therefore, we conducted the present meta-analysis to obtain a more conclusive answer. We searched for eligible articles in PubMed, MEDLINE, EMBASE, Scopus, and CNKI. Odds ratios (ORs) and 95% confidence intervals (CIs) were used to identify any potential associations. Ten case-control studies including 5,292 CHD patients and 5,446 control subjects were analyzed. The overall meta-analysis results showed that the miR-146a rs2910164 polymorphism, the miR-196a2 rs11614913 polymorphism, and the miR-499 rs3746444 polymorphism were all significantly associated with CHD risk in certain genetic models. Besides, the C allele of the miR-146a rs2910164 and miR-499 rs3746444 polymorphisms conferred increased susceptibility to CHD (C versus G, p < 0.0001, OR = 1.14, 95% CI = 1.07–1.21; p = 0.003, OR = 1.14, 95% CI = 1.05–1.25). Overall, our findings suggest that the miR-146a rs2910164, miR-196a2 rs11614913, and miR-499 rs3746444 polymorphisms may be correlated with the risk of CHD.

Moran AE, Forouzanfar MH, Roth G et al (2014) The global burden of Ischemic heart disease in 1990 and 2010: the global burden of disease 2010 study. Circulation 129:1493–1501CrossRefPubMedPubMedCentral

Global Burden of Disease Study 2013 Collaborators (2015) Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 386:743–800CrossRefPubMedCentral

Mayer B, Erdmann J, Schunkert H (2007) Genetics and heritability of coronary artery disease and myocardial infarction. Clin Res Cardiol 96:1–7CrossRefPubMed

Evans A, Van Baal GC, McCarron P et al (2003) The genetics of coronary heart disease: the contribution of twin studies. Twin Res 6:432–441CrossRefPubMed

Kangas-Kontio T, Huotari A, Ruotsalainen H et al (2010) Genetic and environmental determinants of total and high-molecular weight adiponectin in families with low HDL-cholesterol and early onset coronary heart disease. Atherosclerosis 210:479–485CrossRefPubMed

Sayols-Baixeras S, Lluís-Ganella C, Lucas G, Elosua R (2014) Pathogenesis of coronary artery disease: focus on genetic risk factors and identification of genetic variants. Appl Clin Genet 7:15–32PubMedPubMedCentral

Ebert MS, Sharp PA (2012) Roles for microRNAs in conferring robustness to biological processes. Cell 149:515–524CrossRefPubMedPubMedCentral

lshatwi AA, Shafi G, Hasan TN et al (2012) Differential expression profile and genetic variants of microRNAs sequences in breast cancer patients. PLOS ONE 7:e30049CrossRef

Ryan BM, Robles AI, Harris CC (2010) Genetic variation in microRNA networks: the implications for cancer research. Nat Rev Cancer 10:389–402CrossRefPubMedPubMedCentral

10.

Stang A (2010) Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25:603–605CrossRefPubMed

11.

Bastami M, Ghaderian SM, Omrani MD et al (2016) MiRNA-related polymorphisms in miR-146a and TCF21 are associated with increased susceptibility to coronary artery disease in an Iranian population. Genet Test Mol Biomarkers 20:241–248CrossRefPubMed

12.

Chen L, Wu YT (2013) Association of genetic polymorphisms in microRNAs precursor with the risk and prognosis of coronary heart disease. Acad J Xian Jiaotong Univ 34:495–499

13.

Chen C, Hong H, Chen L et al (2014) Association of microRNA polymorphisms with the risk of myocardial infarction in a Chinese population. Tohoku J Exp Med 233:89–94CrossRefPubMed

14.

Hamann L, Glaeser C, Schulz S et al (2014) A micro RNA-146a polymorphism is associated with coronary restenosis. Int J Immunogenet 41:393–396CrossRefPubMed

15.

Huang S, Lv Z, Deng Q et al (2015) A genetic variant in pre-miR-146a (rs2910164 C>G) is associated with the decreased risk of acute coronary syndrome in a Chinese population. Tohoku J Exp Med 237:227–233CrossRefPubMed

16.

Li L (2010) Association of miRNA-146a polymorphism with risk of cardiovascular disease and ischemia stroke and the mechanisms. Dissertation. Central South University, Hunan

17.

Ramkaran P, Khan S, Phulukdaree A et al (2014) miR-146a polymorphism influences levels of miR-146a, IRAK-1, and TRAF-6 in young patients with coronary artery disease. Cell Biochem Biophys 68:259–266CrossRefPubMed

18.

Xiong XD, Cho M, Cai XP et al (2014) A common variant in pre-miR-146 is associated with coronary artery disease risk and its mature miRNA expression. Mutat Res 761:15–20CrossRefPubMed

19.

Yang Y (2012) Common genetic variations in pre-miRNAs and the risk of coronary heart disease in a Chinese Han population. Dissertation. Peking Union Medical College, Beijing

20.

Zhi H, Wang L, Ma G et al (2012) Polymorphisms of miRNAs genes are associated with the risk and prognosis of coronary artery disease. Clin Res Cardiol 101:289–296CrossRefPubMed

21.

Lloyd-Jones DM, Larson MG, Beiser A, Levy D (1999) Lifetime risk of developing coronary heart disease. Lancet 353:89–92CrossRefPubMed

22.

Braunwald E (1997) Shattuck lecture – cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities. N Engl J Med 337:1360–1369CrossRefPubMed

23.

Ambros V (2004) The functions of animal microRNAs. Nature 431:350–355CrossRefPubMed

24.

Hogg DR, Harries LW (2014) Human genetic variation and its effect on miRNA biogenesis, activity and function. Biochem Soc Trans 42:1184–1189CrossRefPubMed

25.

Huang S, Zhou S, Zhang Y et al (2015) Association of the genetic polymorphisms in pre-MicroRNAs with risk of ischemic stroke in a Chinese population. PLOS ONE 10:e0117007CrossRefPubMedPubMedCentral

26.

Shen J, Ambrosone CB, DiCioccio RA et al (2008) A functional polymorphism in the miR-146a gene and age of familial breast/ovarian cancer diagnosis. Carcinogenesis 29:1963–1966CrossRefPubMed

27.

Hoffman AE, Zheng T, Yi C et al (2009) MicroRNA miR-196a-2 and breast cancer: A genetic and epigenetic association study and functional analysis. Cancer Res 69:5970–5977CrossRefPubMedPubMedCentral

28.

El Gazzar GM, Church A, Liu T, McCall CE (2011) MicroRNA-146a regulates both transcription silencing and translation disruption of TNF-a during TLR4-induced gene reprogramming. J Leukoc Biol 90:509–519CrossRefPubMedPubMedCentral

29.

Luthra R, Singh RR, Luthra MG et al (2008) MicroRNA-196a targets annexin A1: A microRNA-mediated mechanism of annexin A1 downregulation in cancers. Oncogene 27:6667–6678CrossRefPubMed

30.

Yang B, Chen J, Li Y et al (2012) Association of polymorphisms in pre-miRNA with inflammatory biomarkers in rheumatoid arthritis in the Chinese Han population. Hum Immunol 73:101–106CrossRefPubMed

Titel: Association between microRNA polymorphisms and coronary heart disease
A meta-analysis
verfasst von: X. Xie, MD
X. Shi, MD
X. Xun, BS
L. Rao, MD, PhD
Publikationsdatum: 10.11.2016
Verlag: Springer Medizin
Erschienen in: Herz / Ausgabe 6/2017
Print ISSN: 0340-9937
Elektronische ISSN: 1615-6692
DOI: https://doi.org/10.1007/s00059-016-4495-4

Neu im Fachgebiet Kardiologie

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Adipositas-Medikament auch gegen Schlafapnoe wirksam

24.04.2024 Adipositas Nachrichten

Der als Antidiabetikum sowie zum Gewichtsmanagement zugelassene Wirkstoff Tirzepatid hat in Studien bei adipösen Patienten auch schlafbezogene Atmungsstörungen deutlich reduziert, informiert der Hersteller in einer Vorab-Meldung zum Studienausgang.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 6/2017

Role of nifedipine and hydrochlorothiazide in MAPK activation and vascular smooth muscle cell proliferation and apoptosis

Treatment of asymptomatic aortic valve stenosis

„Low-flow-low-gradient“-Aortenklappenstenose

Erratum to: Imaging for planning of transcatheter aortic valve implantation

Kardioprotektion über den Arm?